WallStreetZenWallStreetZen

NASDAQ: AGMB
Agomab Therapeutics Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Agomab Therapeutics Nv earnings were -$72.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest AGMB earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$20.5M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AGMB reported annual earnings of -$73.6M, with 52.7% growth.

AGMB earnings history

Current Revenue
$0.0
Current Earnings
-$73.6M
Current Profit Margin
0%

AGMB Return on Equity

Current Company
-39.2%
Current Industry
-31.4%
Current Market
28.9%
AGMB's Return on Equity (-39.2%)... subscribe to Premium to read more.
High Return on Equity Performance

AGMB Return on Assets

Current Company
-34.7%
Current Industry
-9.6%
AGMB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AGMB announces earnings.

AGMB Return on Capital Employed

Current Company
-46.19%
Current Industry
-3.7%

AGMB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AGMB-$72.32M-$72.73MN/A-$166.54
TECX-$69.37M-$74.15MN/A-$4.05
ENGN-$118.31M-$122.44MN/A-$2.25
OCGN-$59.00M-$67.85MN/A-$0.23
KYTX-$156.12M-$161.31MN/A-$3.64
View Top Biotech Stocks

Agomab Therapeutics Nv Earnings Reports & History FAQ

What were Agomab Therapeutics Nv's earnings last quarter?

Agomab Therapeutics Nv (NASDAQ: AGMB) reported Q4 2025 earnings per share (EPS) of -$165.84, up 51.03% year over year. Total AGMB earnings for the quarter were -$20.47 million. In the same quarter last year, Agomab Therapeutics Nv's earnings per share (EPS) was -$109.80.

If you're new to stock investing, here's how to buy Agomab Therapeutics Nv stock.

Is Agomab Therapeutics Nv profitable or losing money?

As of the last Agomab Therapeutics Nv earnings report, Agomab Therapeutics Nv is currently losing money. Agomab Therapeutics Nv's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$73.58 million, a 52.68% increase year over year.

What was AGMB's earnings growth in the past year?

As of Agomab Therapeutics Nv's earnings date in Q2 2026, Agomab Therapeutics Nv's earnings has grown year over year. AGMB earnings in the past year totalled -$72.73 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.